Modulation of neurogenesis by HDac inhibition

Details for Australian Patent Application No. 2006287378 (hide)

Owner BrainCells, Inc.

Inventors Dearie, Alejandro R.; Lorrain, Kym I.; Gitnick, Dana; Pires, Jammieson C.; Treuner, Kai; Morse, Andrew; Barlow, Carrolee; Carter, Todd A.

Agent Spruson & Ferguson

Pub. Number AU-A-2006287378

PCT Pub. Number WO2007/030697

Priority 60/764,963 03.02.06 US; 60/785,713 24.03.06 US; 60/715,219 07.09.05 US

Filing date 7 September 2006

Wipo publication date 15 March 2007

International Classifications

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/19 (2006.01)

A61K 31/4045 (2006.01)

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 38/15 (2006.01) Medicinal preparations containing peptides - Depsipeptides

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/030697 Priority application(s): WO2007/030697

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006287396-Supercritical flat panel collector and methods of use

2006287367-Impedance Measurement System with incorporated internal measurement drift compensation networks